CIP
CNMD icon

Chartwell Investment Partners’s CONMED CNMD Stock Holding History

Chartwell Investment Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,785
Closed -$945K – 411
2022
Q3 		$945K Buy
11,785
+416
+4% +$39.2K 0.04% 355
2022
Q2 		$1.09M Buy
11,369
+282
+3% +$33.8K 0.04% 345
2022
Q1 		$1.65M Sell
11,087
-2,409
-18% -$336K 0.05% 331
2021
Q4 		$1.91M Sell
13,496
-239
-2% -$33.9K 0.06% 313
2021
Q3 		$1.8M Hold
13,735
– – 0.06% 306
2021
Q2 		$1.89M Buy
13,735
+1,053
+8% +$144K 0.06% 302
2021
Q1 		$1.66M Buy
+12,682
New +$1.53M 0.05% 309

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Chartwell Investment Partners's CNMD Position: Q4 2022 in Review

Chartwell Investment Partners sold out of CONMED (CNMD) in Q4 2022, closing a stake of 11,785 shares — an estimated $945K sold.

Chartwell Investment Partners first reported a position in CNMD in Q1 2021 and held it in 7 quarters. The position peaked at $1.91M in Q4 2021. 238 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.

  • Chartwell Investment Partners reported no remaining CONMED position as of Q4 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 11,785 CONMED shares in Q4 2022, an estimated $945K.
  • Chartwell Investment Partners first reported a position in CONMED in Q1 2021 and held it in 7 quarters.
  • Chartwell Investment Partners's CONMED position peaked at $1.91M in Q4 2021.
  • 238 funds tracked by Wall St. Rank held CONMED as of Q4 2022.

Based on Chartwell Investment Partners's 13F filing for Q4 2022, filed 16 Feb 2023.